In a significant development for investors, Barclays analyst Pablo Monsivais upgraded Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (VLRS) to an “Overweight” rating o. This comes alongside a ...

In a recent development that may pique the interest of investors, PACCAR Inc (PCAR) has received an “Overweight” rating from Tami Zakaria of JP Morgan on December 19, 2025. This upgrade not only ...

In a recent development that has caught the attention of investors, Cytokinetics, Incorporated (ticker: CYTK) received a ‘Buy’ rating from analyst Paul Choi of Goldman Sachs o. This reaffirmation ...

ZIM Integrated Shipping Services Ltd. (NASDAQ: ZIM) received a “Hold” rating from Fearnleys analyst Fredrik Dybwad o. This rating comes as ZIM’s stock trades at $19.24, closely matching Fearnleys’ ...

Stryker Corporation (NYSE: SYK) has recently been upgraded to a “Market Outperform” rating by Citizens’ analyst David Turkaly, with a price target set at $440, significantly above its current price of ...

Elevance Health Inc. (ELV) found itself under scrutiny on December 19, 2025, as Deutsche Bank analyst George Hill downgraded the stock to a ‘Hold’ rating. The firm adjusted its price target to $332, ...

On December 19, 2025, Lockheed Martin Corporation (LMT) received a neutral rating from Seth Seifman at JP Morgan, indicating a more cautious outlook for investors. The revised price target of $515, ...

The Eastman Chemical Company (NYSE: EMN) has recently attracted attention following a new Equal-Weight rating from Wells Fargo’s Michael Sison, issued o. The revised rating, paired with a price target ...

Cummins Inc. (CMI) has received an upward rating from Barclays analyst Adam Seiden, who upgraded the stock to “Overweight” o. This favorable change suggests an optimistic outlook for the engine ...

Generac Holdings Inc. (GNRC) received a notable upgrade to Overweight by Wells Fargo analyst Praneeth Satish o. This rating change signals renewed optimism towards the company’s growth potential, with ...

Kristen Kluska of Cantor Fitzgerald issued a neutral rating for Amicus Therapeutics, Inc. (FOLD), while setting a price target of $21. This marks a pivotal moment for investors, as it suggests that ...

Eagle Materials Inc. (NYSE: EXP) has garnered attention from investors as Truist Securities analyst Keith Hughes upgraded the ...